Effect of secretory DKK3 on circulating CD56bright natural killer cells in patients with liver cancer

被引：0
|
作者：
Liu, Da-Hua [1 ]
Wen, Gui-Min [2 ]
Song, Chang-Liang [3 ]
Xia, Pu [1 ,4 ]
机构：
[1] Jinzhou Med Univ, Biol Anthropol Inst, Coll Basic Med Sci, Jinzhou, Liaoning, Peoples R China
[2] Jinzhou Med Univ, Coll Nursing, Dept Community Nursing, Jinzhou, Liaoning, Peoples R China
[3] Ctr Hosp Handan, Dept Radiotherapy, Handan, Hebei, Peoples R China
[4] Jinzhou Med Univ, Biol Anthropol Inst, Jinzhou 121000, Liaoning, Peoples R China
来源：
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS | 2023年 / 38卷 / 02期
基金：
中国国家自然科学基金;
关键词：
Liver cancer; DKK3; NK cells; differentiation; cytotoxicity; NK CELLS; METHYLATION; EXPRESSION; MECHANISM; ALPHA;
D O I：
10.1177/03936155231169796
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
Background Liver cancer seriously threatens human health. Natural killer (NK) cells are an important part of the innate immune system and have strong anti-tumor ability. Immunotherapy based on NK cells has become a hot topic in the treatment of liver cancer. Methods In this study, we checked the serum DKK3 (sDKK3) and circulating CD56(bright) NK cells using ELISA and flow cytometry, respectively, in the blood of liver cancer patients. The effect on recombinant human DKK3 (rhDKK3) on CD56(bright) NK cells was analyzed in vitro. Results We found low levels of sDKK3 in liver cancer patients and a negative correlation between sDKK3 and circulating CD56(bright) NK cells. In addition, we found that DKK3 induced the differentiation and improved the cytotoxicity of CD56(bright) NK cells for the first time. It could be used as an agonist for NK cell-based immunotherapy. Conclusions Improving the clinical efficacy of NK cells through DKK3 will become a new strategy for cancer immunotherapy.
引用
收藏
页码：99 / 104
页数：6
相关论文
共 50 条
  • [31] Expansion of CD56Bright natural killer cells in the peripheral blood of multiple sclerosis patients treated with interferon-beta
    Saraste, M.
    Irjala, H.
    Airas, L.
    NEUROLOGICAL SCIENCES, 2007, 28 (03) : 121 - 126
  • [32] Unaltered frequency and functionality of CD56bright and CD56dim natural killer cells in untreated relapsing-remitting multiple sclerosis patients
    Sisay, Sofia
    Rosello, Alicia
    Henseleit, Korinna
    Tan, Matt
    Marta-caldo, Monica
    Dua, Priya
    Warnes, Gary
    Palace, Jacqueline
    Giovannoni, Gavin
    Meier, Ute-christiane
    JOURNAL OF NEUROIMMUNOLOGY, 2014, 275 (1-2) : 46 - 46
  • [33] Expansion of circulating CD56bright natural killer cells in patients with JAK2-positive chronic myeloproliferative neoplasms during treatment with interferon-α
    Riley, Caroline H.
    Hansen, Morten
    Brimnes, Marie K.
    Hasselbalch, Hans C.
    Bjerrum, Ole W.
    Straten, Per Thor
    Svane, Inge Marie
    Jensen, Morten Krogh
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2015, 94 (03) : 227 - 234
  • [34] Abnormalities of quantities and functions of CD56bright natural killer cells in non-severe aplastic Anemia
    Li, Yang
    Ding, Shaoxue
    Liu, Chunyan
    Chen, Tong
    Liu, Hui
    Li, Lijuan
    Shao, Zonghong
    Fu, Rong
    HEMATOLOGY, 2019, 24 (01) : 405 - 412
  • [35] Timed Sexual Intercourse Facilitates the Recruitment of Uterine CD56bright Natural Killer Cells in Women with Infertility
    Kimura, Hidetaka
    Fukui, Atsushi
    Fujii, Shunsaku
    Yamaguchi, Eiji
    Kasai, Goichiro
    Mizunuma, Hideki
    AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2009, 62 (02) : 118 - 124
  • [36] Peripheral CD56bright Natural Killer Cells Associate With Increased Atheroburden and Unstable Plaque Features in Humans
    Kothari, Hema
    Drago, Fabrizio
    McSkimming, Chantel
    McNamara, Coleen A.
    CIRCULATION, 2020, 142
  • [37] A decreased proportion of CD56bright human natural killer cells in cord blood increases the risk of allergy development
    Sundstrom, Yvonne
    Berg, Louise
    Nilsson, Caroline
    Lilja, Gunnar
    Karre, Klas
    Troye-Blomberg, Marita
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2008, 68 (02) : 232 - 233
  • [38] Il-1β costimulates cytokine production by CD56bright human natural killer (NK) cells.
    Cooper, MA
    Fehniger, TA
    Ghaheri, BA
    Ponnappan, A
    Chen, K
    Caligiuri, MA
    BLOOD, 1999, 94 (10) : 8A - 8A
  • [39] CD56bright Natural Killer Cells Expand and Contract Irrespective of CD25 Antibody Treatment in Kidney Allograft Recipients
    Zenhaeusern, G.
    Hoenger, G.
    Gasser, O.
    Steiger, J.
    Schaub, S.
    Hess, C.
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2009, 69 (05) : 465 - 467
  • [40] Human Natural Killer Cell Maturation Defect Supports In Vivo CD56bright to CD56dim Lineage Development
    Ines Domaica, Carolina
    Beatriz Fuertes, Mercedes
    Uriarte, Ignacio
    Victoria Girart, Maria
    Sardanons, Jessica
    Ileana Comas, Dorina
    Di Giovanni, Daniela
    Isabel Gaillard, Maria
    Bezrodnik, Liliana
    Walter Zwirner, Norberto
    PLOS ONE, 2012, 7 (12):
12345